FDA NDC Directory · JSON-LD · Markdown

Testopel

NDC 66887-004 · HUMAN PRESCRIPTION DRUG · PELLET

Generic nametestosterone
Labeler / ManufacturerEndo USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA080911
Dosage form / routePELLET · SUBCUTANEOUS
Active ingredientsTESTOSTERONE (75 mg/1)
Marketing started20141031
Package count2

External sources

Source: openFDA. Public-domain (CC0).